Home > Guide to import and export licences and letters of no objection for controlled drugs (including the import of cannabis products for medical use).

Health Products Regulatory Authority. (2022) Guide to import and export licences and letters of no objection for controlled drugs (including the import of cannabis products for medical use). Dublin: Health Products Regulatory Authority.

[img]
Preview
PDF (Guide to import and export licences and letters of no objection for controlled drugs) - Published Version
235kB

External website: https://www.lenus.ie/handle/10147/635103


Operators (manufacturers, wholesalers, authorised persons) require a controlled drugs licence or registration processed by the Health Products Regulatory Authority (HPRA) on behalf of the Department of Health if they wish to produce/manufacture, supply, import, export or possess any controlled drug in the Schedules to the Misuse of Drugs Regulations 2017

Item Type
Report
Publication Type
Irish-related, Guideline, Report
Drug Type
Cannabis
Intervention Type
Treatment method
Date
December 2022
Pages
15 p.
Publisher
Health Products Regulatory Authority
Corporate Creators
Health Products Regulatory Authority
Place of Publication
Dublin
EndNote

Repository Staff Only: item control page